Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Transparency proposal feedback: Comments are due July 20 on information FDA is considering making available to the public, the agency noted on its "transparency blog" last week. The agency released 21 draft 1proposals May 19, including ideas such as allowing FDA to publicly explain why it rejects certain product applications, share information about FDA inspections or common inspection problems, and give doctors and patients summaries of safety and effectiveness data from medical product applications (2"The Gray Sheet" May 24, 2010)
You may also be interested in...
CDRH Pre-Market Reform Proposals Expected Within Weeks
The FDA device center's upcoming proposals for reforming its pre-market policies will directly address widespread industry concern that reviews are increasingly unpredictable and opaque, CDRH Director Jeff Shuren told an industry audience last week
FDA Unveils 21 Policy Changes To Increase Transparency With Public
FDA may publicly disclose more information on specific devices prior to marketing approval under a May 19 proposal to increase transparency
Attendees Air 510(k) Concerns At CDRH Town Hall In Minnesota
Not surprisingly, questions and fears surrounding 510(k) reform dominated a "town hall" forum held by CDRH Director Jeffrey Shuren and other center managers in Minneapolis May 18